← Leaderboards
John T Ransom
Novasite Pharmaceuticals, Inc.
$1,194,279
Attributed
$1,194,279
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,194,279 · 2
By mechanism
R01$944,279 · 1
R43$250,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Novasite Pharmaceuticals, Inc.
Same institution · by research overlap
- William D Huse$3,224,577
- Juan Ballesteros$2,466,310
- Teresa Bennett$1,383,907
- David Salom$2,073,551
Others in their field
Top investigators on “Cell Surface Receptors”
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$45,640,184
- Michael S. Diamond · University Of Pittsburgh At Pittsburgh$25,442,645
- Ellis L Reinherz · Dana-Farber Cancer Institute$23,850,945
- Martin Friedlander · Scripps Research Institute$19,787,979
- Ronald L Schnaar · Johns Hopkins University$19,571,340
- Roger A Nicoll · University Of California San Francisco$19,105,813
Research focus
Cell Surface ReceptorsTechnology /Technique DevelopmentFlow CytometryCell LineDrug Discovery /IsolationChemical KineticsComputational BiologyCytotoxicityDrug Screening /EvaluationHigh Throughput TechnologyProteomicsSerotoninTissue /Cell CultureToxicant ScreeningBiochemical EvolutionTransfectionBioengineering /Biomedical EngineeringBioinformaticsBiomedical Equipment DevelopmentBiotechnology